82 percent of Americans say the cost of prescription drugs is too high and 73 percent say that the Government is not doing enough to regulate drug prices.

82 percent of Americans say the cost of prescription drugs is too high and 73 percent say that the Government is not doing enough to regulate drug prices.

Over the past 25 years, the pharmaceutical industry... spent over $8.5 billion on lobbying and more than $745 million on campaign contributions.

the cost of prescription drugs in this country is putting an enormous burden on taxpayers and seniors by raising the cost of Medicare and Medicaid.

Americans are forced to pay higher and higher prices for the drugs they need to survive.

Would it have been consistent with Judge Merck's philosophy to take research funded by my father's tax dollars?

Over the past 25 years, the pharmaceutical industry... spent over $8.5 billion on lobbying and more than $745 million on campaign contributions.

Adam Smith hated monopolies. It was the No. 1 thing he hated the most, monopolies.

the need to substantially lower the outrageous price of prescription drugs in this country.

I am especially impressed by the Pfizer drug company--Pfizer is not here this morning contributing $1 million to the Republican Party in Kentucky.

I am especially impressed by the Pfizer drug company--Pfizer is not here this morning contributing $1 million to the Republican Party in Kentucky.

I have long said to the Chair that I am very concerned about PBMs because we might fight with you about whether you are researching enough or should your research be more than your stock buybacks.

Adam Smith hated monopolies. It was the No. 1 thing he hated the most, monopolies.

Let's be clear, Johnson & Johnson, Merck, and Bristol-Myers Squibb are not just charging higher prices in the United States compared to other countries.

10 of the top pharmaceutical companies in America made over $110 billion in profits in 2022.

10 of the top pharmaceutical companies in America made over $110 billion in profits in 2022.

I have long said to the Chair that I am very concerned about PBMs because we might fight with you about whether you are researching enough or should your research be more than your stock buybacks.

The overwhelming beneficiary of these high drug prices is the pharmaceutical industry.